Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Mouse Biology Program Supports Research Into Innovative Neuropathic Pain Research

Posted on February 14, 2024

A groundbreaking study at the University of Texas at Austin, highlighted by NIH Director Dr. Monica M. Bertagnolli, has brought new hope to the treatment of neuropathic pain, thanks to the utilization of KOMP (Knockout Mouse Project) mice modified by the Mouse Biology Program at UC Davis. This NIH-funded research has identified a novel molecule that targets a protein involved in the transmission of neuropathic pain, offering a potential new pathway for therapeutic intervention.

The study’s focus on a molecule that can bind to and modulate a protein implicated in neuropathic pain—pain resulting from damage to the nervous system—represents a significant advance in understanding and treating this complex condition. The KOMP mice, specifically engineered for such scientific investigations, were instrumental in the research, providing a crucial model for studying neuropathic pain’s molecular and genetic underpinnings.

Dr. Bertagnolli lauded the efforts of the researchers and the role of mouse models in the discovery. It is NIH funding that provided support in the creation of this knockout mouse model, and while not highlighted in Dr. Bertagnolli’s post, it serves the purpose of the vital work done at the Mouse Biology Program and our support services for researchers and importance in scientific discoveries.

The NIH Director’s Tweet about the research is found here:

https://twitter.com/NIHDirector/status/1757170335361982975